Dipak Kotecha

Oct 29, 2024 | nature.com | Olalekan Lee Aiyegbusi |Alastair K Denniston |Rosie Harding |Sarah Hughes |Dipak Kotecha |Harlan M. Krumholz | +3 more

AbstractDecentralized clinical trials involving the use of digital tools to facilitate remote research are gaining momentum. Rapid advancements in digital technologies have supported the adoption of these trials. These innovations facilitate virtual interactions between clinical trial teams and participants by making it easier to collect, transfer and store electronic data.

Sep 2, 2024 | radcliffecardiology.com | Gi-Byoung Nam |Harriette Van Spall |Rick A Veasey |Dipak Kotecha

ESC Congress 24 — SHAM-PVI study finds pulmonary vein isolation effective in reducing atrial fibrillation (AF) episodes, improving quality of life. We are joined onsite by Dr Rick Veasey (Eastbourne District General Hospital, Eastbourne, UK) to discuss the findings from a SHAM-PVI, a randomized sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation (NCT04272762; East Sussex Hospitals NHS Trust).

Sep 1, 2024 | radcliffecardiology.com | Mirvat Alasnag |Dipak Kotecha |Mohammad Iqbal |William Kamarullah

ESC Congress 2024 — Improved patient-level adherence to guideline recommendations on heart rhythm control through healthcare professional education in patients with atrial fibrillation. Investigator, Dr Dipak Kotecha (University of Birmingham, UK) joins us in London to share key findings from the STEEER-AF study (NCT04396418). This prospective, cluster-randomized international study compared two groups of healthcare professionals caring for atrial fibrillation (AF) patients.

Sep 1, 2024 | radcliffecardiology.com | Gi-Byoung Nam |Dipak Kotecha |Renato D. Lopes

ESC Congress 24 — AF screening with a wearable ECG device increases diagnosis by over 50% but did not significantly reduce hospitalisation rates for stroke.